Dr. Hirshman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2301 Erwin Rd.
Durham, NC 27710Phone+1 703-376-1378- Is this information wrong?
Education & Training
- Duke University School of MedicineClass of 2019
Certifications & Licensure
- NC State Medical License 2019 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsLR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions.Tzu-Hao Lee, Nathan Hirshman, Diana M Cardona, Carl L Berg, Kathryn J Fowler, Mustafa R Bashir, James Ronald> ;Digestive Diseases and Sciences. 2022 Nov 1
- 4 citationsThe management of toxicities from immune, targeted and ADCs treatments in patients with urothelial cancer.Saad Atiq, Nathan Hirshman, Afreen Shariff, Tian Zhang> ;Urologic Oncology. 2023 Oct 1
- 17 citationsAssociation of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma.Matthew D. Tucker, Landon C. Brown, Yu-Wei Chen, Chester Kao, Nathan Hirshman, Emily N. Kinsey, Kristin Kathleen Ancell, Kathryn E. Beckermann, Nancy B. Davis, Renee M...> ;Biomarker Research. 2021 Nov 3
- Join now to see all
Press Mentions
- Management of Men with Metastatic Castration-Resistant Prostate Cancer Following Potent Androgen Receptor Inhibition: A Review of Novel Investigational TherapiesNovember 9th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: